Fertility and Sterility
Volume 84, Issue 1 , Pages 181-185 , July 2005

Pituitary imaging is indicated for the evaluation of hyperprolactinemia

Presented at the 51st Annual Meeting of the Pacific Coast Reproductive Society, April 23–27, 2003, Rancho Mirage, California.

  • Aykut Bayrak, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California
    • Corresponding Author InformationReprint requests: Aykut Bayrak, M.D., Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, 1240 N Mission Road, Room 8K9, Los Angeles, California 90033 (FAX: 323-226-2850
    • ,
  • Peyman Saadat, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California
    • ,
  • Eliran Mor, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California
    • ,
  • Lisa Chong, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California
    • ,
  • Richard J. Paulson, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California
    • ,
  • Rebecca Z. Sokol, M.D., M.P.H.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California
    • Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California

Received 1 June 2004 ,Accepted 4 January 2005.

References 

  1. Miyai K , Ichihara K , Kondo K , Mori S . Asymptomatic hyperprolactinaemia and prolactinoma in the general population (mass screening by paired assays of serum prolactin) . Clin Endocrinol . 1986;25:549–554
  2. Biller BM , Luciano A , Crosignani PG , Molitch M , Olive D , Rebar R , et al.   Guidelines for the diagnosis and treatment of hyperprolactinemia . J Rep Med . 1999;44(Suppl):12
  3. Mah PM , Webster MA . Hyperprolactinemia (etiology, diagnosis, and management) . Semin Repro Med . 2002;20:365–373
  4. Speroff L , Glass RH , Kase NG . Clinical gynecologic endocrinology and infertility . 6th ed.. Baltimore: Lippincott Williams & Wilkins; 1999; ch. 5, 11, 16
  5. Kulkarni MV , Lee KF , McArdle CB , Yeakley JW , Haar FL . 1.5-T MR imaging of pituitary microadenomas (technical considerations and CT correlation) . Am J Neurorad . 1987;9:5–11
  6. Rand T , Kink E , Sator M , Schneider B , Huber J , Imhof H , et al.   MRI of microadenomas in patients with hyperprolactinemia . Neurorad . 1996;38:744–746
  7. Drange MR , Fram NR , Herman-Bonert V , Melmed S . Pituitary tumor registry (a novel clinical resource) . J Clin Endocrinol Metab . 2000;85:168–174
  8. Molitch ME . Pituitary incidentalomas . Endocrinol Metab Clin North Am . 1997;26:725–740
  9. Tang LCH , Sung ML , Ma HK . Hyperprolactinemic amenorrhoea in Hong Kong . Aust N Z J Obstet Gynaec . 1983;23:165–169
  10. Davajan V , Kletzky O , March CM , Roy S , Mishell DR . The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea . Am J Obstet Gynecol . 1978;130:894–904
  11. Donald RA , Espiner EA , Livesey JH . Treatment of amenorrhea, galactorrhea and hypogonadism with bromocriptine . Aust N Z J Med . 1978;8:262–266
  12. Raber W , Gessl A , Nowotny P , Vierhapper H . Hyperprolactinemia in hypothyroidism (clinical significance and impact of TSH normalization) . Clin Endocrin . 2003;58:185–191
  13. Hauche O , Rocha AJ , Maia ACM , Maciel RMB , Vieira JGH . Screening for macroprolactinaemia and pituitary imaging studies . Clin Endocrinol . 2002;57:327–331
  14. Colao A , Di Sarno A , Cappabianca P , Di Somma C , Pivonello R , Lombardi G . Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia . N Engl J Med . 2003;349:2023–2033
  15. Valette-Kasic S , Morange-Ramos I , Selim A , Gunz G , Morange S , Enjalbert A , et al.   Macroprolactinemia revisited (a study of 106 patients) . J Clin Endocrinol Metab . 2002;87:581–588
  16. Nomikos P , Buchfelder M , Fahlbusch R . Current management of prolactinomas . J Neurooncol . 2001;54:139–150
  17. Petakov MS , Damjanovic SS , Nikolic-Durovic MM , Dragojlovic ZL , Obradovic S , Gligoric MS , et al.   Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect . J Endocrinol Invest . 1998;21:184–188
  18. St-Jean E , Blain F , Comtois R . High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas . Clin Endocrinol . 1996;44:305–309
  19. Luciano AA , Chapler FK , Sherman BM . Hyperprolactinemia in polycystic ovary syndrome . Fertil Steril . 1984;41:719–725
  20. Falaschi P , del Pozo E , Rocco A , Toscano V , Petrangeli E , Pompei P , et al.   Prolactin release in polycystic ovary . Obstet Gynecol . 1980;55:579–582
  21. Carmina E , Rosato F , Maggiore M , Gagliano AM , Indovina D , Janni A . Prolactin secretion in polycystic ovary syndrome (PCOS) (correlation with the steroid pattern) . Acta Endocrinol . 1984;105:99–104

PII: S0015-0282(05)00567-4

doi: 10.1016/j.fertnstert.2005.01.102

Fertility and Sterility
Volume 84, Issue 1 , Pages 181-185 , July 2005

Article Tools

* Image Usage & Resolution